Quest Diagnostics, Inc. (NYSE:DGX)

CAPS Rating: 4 out of 5

A provider of diagnostic testing, information and services, providing insights that enable physicians and other healthcare professionals to make decisions to improve health.

Recs

1
Player Avatar zycantodan (90.52) Submitted: 3/7/2011 11:26:23 AM : Outperform Start Price: $53.63 DGX Score: -35.40

Clean facilities and well-integrated IT systems from the patient side - you can schedule appointments online and find locations easily. This significantly cuts down on in-office wait time. All labeling is automated and efficient. I would assume the back-office IT is run as smoothly as the customer-facing side to allow for more efficiencies, but I could be wrong. Appears cheap/similar-price relative to peers although it is the dominant player. With aging population need for DGX services will increase

Featured Broker Partners


Advertisement